MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.15

-0.3%

Nov 3 1:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A.J. Mullen who wrote (1981)	4/26/2008 3:14:46 AM
From: Icebrg	of 2240

Medarex has consistently claimed that FDA's decision will be based on the "totality of the trial data". It seems that this is exactly what they have now got. On the other hand, I don't see how they are going to be able to squeeze anything meaningful from the uncontrolled trials, unless there will be a striking number of long-time survivors. But that will take time to establish. Maybe, they will be able to use some from the "025-study", in which they have continued to treat patients who were progressing in any of the three original registration trials. But, who knows how much time that will require. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next